Considerations for β-lactam antimicrobial continuous infusion. Authors' reply to Massart et al. and Marzaroli et al

Affiliations

• ¹ Pharmacy Department, Whiston Hospital, Mersey and West Lancashire Teaching Hospital NHS Trust, Prescot, UK.
• ² Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
• ³ School of Nursing, Midwifery, Social Work and Counselling, The University of Queensland, Brisbane, QLD, Australia.
• ⁴ Herston Infectious Diseases Institute (HeIDI), Metro North Health, Brisbane, Australia.
• ⁵ Alliance for Vascular Access Teaching and Research, Griffith University, Gold Coast, QLD, Australia.
• ⁶ Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia. j.roberts@uq.edu.au.
• ⁷ Herston Infectious Diseases Institute (HeIDI), Metro North Health, Brisbane, Australia. j.roberts@uq.edu.au.
• ⁸ Departments of Intensive Care Medicine and Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, Australia. j.roberts@uq.edu.au.
• ⁹ Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France. j.roberts@uq.edu.au.
• ¹⁰ Level 8 University of Queensland Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women's Hospital, Herston, Australia. j.roberts@uq.edu.au.